Filing Details

Accession Number:
0001144204-16-121745
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-08-29 16:11:27
Reporting Period:
2016-08-26
Filing Date:
2016-08-29
Accepted Time:
2016-08-29 16:11:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1012477 Flamel Technologies Sa FLML Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1207106 R Craig Stapleton 33, Avenue Du Docteur Georges Levy
Venissieux I0 69693
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Adss Acquisiton 2016-08-26 10,878 $13.83 10,878 No 4 P Indirect By Spouse
Adss Acquisiton 2016-08-26 9,122 $13.67 20,000 No 4 P Indirect By Spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Spouse
No 4 P Indirect By Spouse
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Adss 509,678 Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Adss Warrants (right to buy) $14.54 2015-06-24 2018-06-24 100,000 100,000 Direct
Adss Warrants (right to buy) $21.67 2016-06-26 2018-06-24 117,449 117,449 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2018-06-24 100,000 100,000 Direct
2018-06-24 117,449 117,449 Direct
Footnotes
  1. The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value 0.122 Euros per share, of the issuer; ADSs are represented by American Depositary Receipts.
  2. The filing of this statement shall not be construed as an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the beneficial owner of these securities.
  3. Warrants were granted 06/24/2014 but were not exercisable until the first anniversary of the date of grant; on such first anniversary the warrants became exercisable for a 3-year period as to all 100,000 ADSs. The warrant exercise price per ADS may be paid in U.S. Dollars as shown in Item 4 of Table II or in Euros based on the exchange rate prevailing on the date of grant, or (euro)10.94 per ADS.
  4. Warrants were granted 06/26/2015 but are not exercisable until the first anniversary of the date of grant; on such first anniversary the warrants will become exercisable for a 3-year period as to all 117,449 ADSs. The warrant exercise price per ADS may be paid in U.S. Dollars as shown in Item 4 of Table II or in Euros based on the exchange rate prevailing on the date of grant, or (euro)19.34 per ADS. Warrants as to all 117,449 ADSs vest on 06/26/2016.